Fjarde Ap-fonden’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-68,005
Closed -$12.5M 567
2021
Q2
$12.5M Sell
68,005
-3,100
-4% -$569K 0.11% 177
2021
Q1
$10.9M Buy
71,105
+1,300
+2% +$199K 0.1% 207
2020
Q4
$10.9M Sell
69,805
-7,000
-9% -$1.09M 0.1% 188
2020
Q3
$8.79M Buy
76,805
+8,300
+12% +$950K 0.1% 199
2020
Q2
$7.69M Buy
68,505
+4,600
+7% +$516K 0.1% 213
2020
Q1
$5.74M Sell
63,905
-1,100
-2% -$98.8K 0.09% 212
2019
Q4
$7.03M Buy
65,005
+4,800
+8% +$519K 0.09% 242
2019
Q3
$5.9M Buy
60,205
+4,309
+8% +$422K 0.08% 275
2019
Q2
$7.32M Sell
55,896
-7,100
-11% -$930K 0.09% 241
2019
Q1
$8.52M Buy
62,996
+12,064
+24% +$1.63M 0.11% 204
2018
Q4
$4.96M Sell
50,932
-8,100
-14% -$789K 0.09% 242
2018
Q3
$8.21M Sell
59,032
-2,600
-4% -$361K 0.12% 185
2018
Q2
$7.65M Buy
61,632
+349
+0.6% +$43.3K 0.12% 192
2018
Q1
$6.83M Sell
61,283
-104
-0.2% -$11.6K 0.1% 214
2017
Q4
$7.34M Buy
61,387
+8,916
+17% +$1.07M 0.11% 200
2017
Q3
$7.36M Buy
52,471
+1,039
+2% +$146K 0.14% 169
2017
Q2
$6.26M Buy
51,432
+6,879
+15% +$837K 0.13% 181
2017
Q1
$5.4M Sell
44,553
-3,460
-7% -$420K 0.13% 180
2016
Q4
$5.87M Sell
48,013
-4,642
-9% -$568K 0.14% 168
2016
Q3
$6.45M Buy
52,655
+1,083
+2% +$133K 0.14% 161
2016
Q2
$6.02M Buy
51,572
+206
+0.4% +$24.1K 0.14% 167
2016
Q1
$7.15M Buy
51,366
+6,369
+14% +$887K 0.17% 139
2015
Q4
$8.58M Buy
44,997
+610
+1% +$116K 0.23% 99
2015
Q3
$6.94M Sell
44,387
-2,861
-6% -$447K 0.19% 118
2015
Q2
$8.54M Buy
47,248
+2,532
+6% +$458K 0.21% 112
2015
Q1
$7.75M Sell
44,716
-2,237
-5% -$388K 0.18% 131
2014
Q4
$8.69M Sell
46,953
-3,262
-6% -$604K 0.19% 119
2014
Q3
$8.33M Sell
50,215
-4,120
-8% -$683K 0.18% 128
2014
Q2
$8.49M Sell
54,335
-1,992
-4% -$311K 0.17% 138
2014
Q1
$8.57M Buy
56,327
+2,012
+4% +$306K 0.17% 137
2013
Q4
$7.23M Sell
54,315
-3,476
-6% -$463K 0.15% 150
2013
Q3
$6.71M Sell
57,791
-4,288
-7% -$498K 0.14% 161
2013
Q2
$5.73M Buy
+62,079
New +$5.73M 0.12% 196